Global Lipid Nanoparticle (LNP) Formulation Service Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Solid Lipid Nanoparticles
  • 1.2.3 Nanostructured Lipid Carriers
  • 1.2.4 Cationic Lipid-Nucleic Acid Complexes
• 1.3 Market by Application
  • 1.3.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Gene Therapy
  • 1.3.3 Vaccine Development
  • 1.3.4 Cancer Treatment
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Perspective (2020-2031)
• 2.2 Global Lipid Nanoparticle (LNP) Formulation Service Growth Trends by Region
  • 2.2.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2020-2031)
• 2.3 Lipid Nanoparticle (LNP) Formulation Service Market Dynamics
  • 2.3.1 Lipid Nanoparticle (LNP) Formulation Service Industry Trends
  • 2.3.2 Lipid Nanoparticle (LNP) Formulation Service Market Drivers
  • 2.3.3 Lipid Nanoparticle (LNP) Formulation Service Market Challenges
  • 2.3.4 Lipid Nanoparticle (LNP) Formulation Service Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Lipid Nanoparticle (LNP) Formulation Service by Players
  • 3.1.1 Global Lipid Nanoparticle (LNP) Formulation Service Revenue by Players (2020-2025)
  • 3.1.2 Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Players (2020-2025)
• 3.2 Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Ranking by Revenue, 2023 VS 2024 VS 2025
• 3.4 Global Market Concentration Ratio
  • 3.4.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticle (LNP) Formulation Service Revenue in 2024
• 3.5 Global Key Players of Lipid Nanoparticle (LNP) Formulation Service Head office and Area Served
• 3.6 Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Product and Application
• 3.7 Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Lipid Nanoparticle (LNP) Formulation Service Historic Market Size by Type (2020-2025)
• 4.2 Global Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

• 5.1 Global Lipid Nanoparticle (LNP) Formulation Service Historic Market Size by Application (2020-2025)
• 5.2 Global Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Application (2026-2031)

6 North America

• 6.1 North America Lipid Nanoparticle (LNP) Formulation Service Market Size (2020-2031)
• 6.2 North America Market Size by Type
  • 6.2.1 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2031)
  • 6.2.2 North America Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)
• 6.3 North America Market Size by Application
  • 6.3.1 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2031)
  • 6.3.2 North America Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)
• 6.4 North America Market Size by Country
  • 6.4.1 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country: 2020 VS 2024 VS 2031
  • 6.4.2 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2020-2031)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size (2020-2031)
• 7.2 Europe Market Size by Type
  • 7.2.1 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2031)
  • 7.2.2 Europe Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)
• 7.3 Europe Market Size by Application
  • 7.3.1 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2031)
  • 7.3.2 Europe Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)
• 7.4 Europe Market Size by Country
  • 7.4.1 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country: 2020 VS 2024 VS 2031
  • 7.4.2 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2020-2025)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Lipid Nanoparticle (LNP) Formulation Service Market Size (2020-2031)
• 8.2 China Market Size by Type
  • 8.2.1 China Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2031)
  • 8.2.2 China Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)
• 8.3 China Market Size by Application
  • 8.3.1 China Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2031)
  • 8.3.2 China Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Lipid Nanoparticle (LNP) Formulation Service Market Size (2020-2031)
• 9.2 Asia Market Size by Type
  • 9.2.1 Asia Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2031)
  • 9.2.2 Asia Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)
• 9.3 Asia Market Size by Application
  • 9.3.1 Asia Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2031)
  • 9.3.2 Asia Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)
• 9.4 Asia Market Size by Region
  • 9.4.1 Asia Lipid Nanoparticle (LNP) Formulation Service Market Size by Region: 2020 VS 2024 VS 2031
  • 9.4.2 Asia Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2020-2031)
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 China Taiwan
  • 9.4.6 Southeast Asia
  • 9.4.7 India
  • 9.4.8 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size (2020-2031)
• 10.2 Middle East, Africa, and Latin America Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2031)
  • 10.2.2 Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)
• 10.3 Middle East, Africa, and Latin America Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2031)
  • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
• 10.4 Middle East, Africa, and Latin America Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country: 2020 VS 2024 VS 2031
  • 10.4.2 Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2020-2031)
  • 10.4.3 Brazil
  • 10.4.4 Mexico
  • 10.4.5 Turkey
  • 10.4.6 Saudi Arabia
  • 10.4.7 Israel
  • 10.4.8 GCC Countries

11 Key Players Profiles

• 11.1 GenScript
  • 11.1.1 GenScript Company Details
  • 11.1.2 GenScript Business Overview
  • 11.1.3 GenScript Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.1.4 GenScript Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.1.5 GenScript Recent Development
• 11.2 Creative Biolabs
  • 11.2.1 Creative Biolabs Company Details
  • 11.2.2 Creative Biolabs Business Overview
  • 11.2.3 Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.2.4 Creative Biolabs Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.2.5 Creative Biolabs Recent Development
• 11.3 Merck
  • 11.3.1 Merck Company Details
  • 11.3.2 Merck Business Overview
  • 11.3.3 Merck Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.3.4 Merck Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.3.5 Merck Recent Development
• 11.4 Cytiva
  • 11.4.1 Cytiva Company Details
  • 11.4.2 Cytiva Business Overview
  • 11.4.3 Cytiva Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.4.4 Cytiva Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.4.5 Cytiva Recent Development
• 11.5 WuXi STA
  • 11.5.1 WuXi STA Company Details
  • 11.5.2 WuXi STA Business Overview
  • 11.5.3 WuXi STA Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.5.4 WuXi STA Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.5.5 WuXi STA Recent Development
• 11.6 Carcell
  • 11.6.1 Carcell Company Details
  • 11.6.2 Carcell Business Overview
  • 11.6.3 Carcell Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.6.4 Carcell Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.6.5 Carcell Recent Development
• 11.7 Croda International
  • 11.7.1 Croda International Company Details
  • 11.7.2 Croda International Business Overview
  • 11.7.3 Croda International Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.7.4 Croda International Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.7.5 Croda International Recent Development
• 11.8 Detai Biotechnology
  • 11.8.1 Detai Biotechnology Company Details
  • 11.8.2 Detai Biotechnology Business Overview
  • 11.8.3 Detai Biotechnology Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.8.4 Detai Biotechnology Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.8.5 Detai Biotechnology Recent Development
• 11.9 Waters
  • 11.9.1 Waters Company Details
  • 11.9.2 Waters Business Overview
  • 11.9.3 Waters Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.9.4 Waters Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.9.5 Waters Recent Development
• 11.10 MicroNano Biologics
  • 11.10.1 MicroNano Biologics Company Details
  • 11.10.2 MicroNano Biologics Business Overview
  • 11.10.3 MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.10.4 MicroNano Biologics Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.10.5 MicroNano Biologics Recent Development
• 11.11 Precigenome
  • 11.11.1 Precigenome Company Details
  • 11.11.2 Precigenome Business Overview
  • 11.11.3 Precigenome Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.11.4 Precigenome Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.11.5 Precigenome Recent Development
• 11.12 Evonik
  • 11.12.1 Evonik Company Details
  • 11.12.2 Evonik Business Overview
  • 11.12.3 Evonik Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.12.4 Evonik Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.12.5 Evonik Recent Development
• 11.13 Avanti Polar Lipids
  • 11.13.1 Avanti Polar Lipids Company Details
  • 11.13.2 Avanti Polar Lipids Business Overview
  • 11.13.3 Avanti Polar Lipids Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.13.4 Avanti Polar Lipids Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.13.5 Avanti Polar Lipids Recent Development
• 11.14 Genevant Sciences
  • 11.14.1 Genevant Sciences Company Details
  • 11.14.2 Genevant Sciences Business Overview
  • 11.14.3 Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.14.4 Genevant Sciences Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.14.5 Genevant Sciences Recent Development
• 11.15 Nippon Fine Chemical
  • 11.15.1 Nippon Fine Chemical Company Details
  • 11.15.2 Nippon Fine Chemical Business Overview
  • 11.15.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.15.4 Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.15.5 Nippon Fine Chemical Recent Development
• 11.16 Lipoid
  • 11.16.1 Lipoid Company Details
  • 11.16.2 Lipoid Business Overview
  • 11.16.3 Lipoid Lipid Nanoparticle (LNP) Formulation Service Introduction
  • 11.16.4 Lipoid Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)
  • 11.16.5 Lipoid Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Solid Lipid Nanoparticles

Table 3. Key Players of Nanostructured Lipid Carriers

Table 4. Key Players of Cationic Lipid-Nucleic Acid Complexes

Table 5. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Market Size by Region (2020-2031) & (US$ Million)

Table 8. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Region (2020-2031)

Table 9. Market Trends

Table 10. Market Drivers

Table 11. Market Challenges

Table 12. Market Restraints

Table 13. Global Lipid Nanoparticle (LNP) Formulation Service Revenue by Players (2020-2025) & (US$ Million)

Table 14. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Players (2020-2025)

Table 15. Global Top Lipid Nanoparticle (LNP) Formulation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Nanoparticle (LNP) Formulation Service as of 2024)

Table 16. Global Lipid Nanoparticle (LNP) Formulation Service Industry Ranking 2023 VS 2024

Table 17. Global 5 Largest Players Market Share by Lipid Nanoparticle (LNP) Formulation Service Revenue (CR5 and HHI) & (2020-2025)

Table 18. Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Headquarters and Area Served

Table 19. Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Product and Application

Table 20. Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Date of Enter into This Industry

Table 21. Mergers & Acquisitions, Expansion Plans

Table 22. Global Market Size by Type (2020-2025) & (US$ Million)

Table 23. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Type (2020-2025)

Table 24. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 25. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Type (2026-2031)

Table 26. Global Market Size by Application (2020-2025) & (US$ Million)

Table 27. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Application (2020-2025)

Table 28. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 29. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Application (2026-2031)

Table 30. North America Market Size by Type (2020-2031) & (US$ Million)

Table 31. North America Market Size by Application (2020-2031) & (US$ Million)

Table 32. North America Lipid Nanoparticle (LNP) Formulation Service Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Market Size by Country (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 35. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 36. Europe Lipid Nanoparticle (LNP) Formulation Service Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 38. China Market Size by Type (2020-2031) & (US$ Million)

Table 39. China Market Size by Application (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 41. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 42. Asia Lipid Nanoparticle (LNP) Formulation Service Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 46. Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 48. GenScript Company Details

Table 49. GenScript Business Overview

Table 50. GenScript Lipid Nanoparticle (LNP) Formulation Service Product

Table 51. GenScript Revenue (2020-2025) & (US$ Million)

Table 52. GenScript Recent Development

Table 53. Creative Biolabs Company Details

Table 54. Creative Biolabs Business Overview

Table 55. Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Product

Table 56. Creative Biolabs Revenue (2020-2025) & (US$ Million)

Table 57. Creative Biolabs Recent Development

Table 58. Merck Company Details

Table 59. Merck Business Overview

Table 60. Merck Lipid Nanoparticle (LNP) Formulation Service Product

Table 61. Merck Revenue (2020-2025) & (US$ Million)

Table 62. Merck Recent Development

Table 63. Cytiva Company Details

Table 64. Cytiva Business Overview

Table 65. Cytiva Lipid Nanoparticle (LNP) Formulation Service Product

Table 66. Cytiva Revenue (2020-2025) & (US$ Million)

Table 67. Cytiva Recent Development

Table 68. WuXi STA Company Details

Table 69. WuXi STA Business Overview

Table 70. WuXi STA Lipid Nanoparticle (LNP) Formulation Service Product

Table 71. WuXi STA Revenue (2020-2025) & (US$ Million)

Table 72. WuXi STA Recent Development

Table 73. Carcell Company Details

Table 74. Carcell Business Overview

Table 75. Carcell Lipid Nanoparticle (LNP) Formulation Service Product

Table 76. Carcell Revenue (2020-2025) & (US$ Million)

Table 77. Carcell Recent Development

Table 78. Croda International Company Details

Table 79. Croda International Business Overview

Table 80. Croda International Lipid Nanoparticle (LNP) Formulation Service Product

Table 81. Croda International Revenue (2020-2025) & (US$ Million)

Table 82. Croda International Recent Development

Table 83. Detai Biotechnology Company Details

Table 84. Detai Biotechnology Business Overview

Table 85. Detai Biotechnology Lipid Nanoparticle (LNP) Formulation Service Product

Table 86. Detai Biotechnology Revenue (2020-2025) & (US$ Million)

Table 87. Detai Biotechnology Recent Development

Table 88. Waters Company Details

Table 89. Waters Business Overview

Table 90. Waters Lipid Nanoparticle (LNP) Formulation Service Product

Table 91. Waters Revenue (2020-2025) & (US$ Million)

Table 92. Waters Recent Development

Table 93. MicroNano Biologics Company Details

Table 94. MicroNano Biologics Business Overview

Table 95. MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Product

Table 96. MicroNano Biologics Revenue (2020-2025) & (US$ Million)

Table 97. MicroNano Biologics Recent Development

Table 98. Precigenome Company Details

Table 99. Precigenome Business Overview

Table 100. Precigenome Lipid Nanoparticle (LNP) Formulation Service Product

Table 101. Precigenome Revenue (2020-2025) & (US$ Million)

Table 102. Precigenome Recent Development

Table 103. Evonik Company Details

Table 104. Evonik Business Overview

Table 105. Evonik Lipid Nanoparticle (LNP) Formulation Service Product

Table 106. Evonik Revenue (2020-2025) & (US$ Million)

Table 107. Evonik Recent Development

Table 108. Avanti Polar Lipids Company Details

Table 109. Avanti Polar Lipids Business Overview

Table 110. Avanti Polar Lipids Lipid Nanoparticle (LNP) Formulation Service Product

Table 111. Avanti Polar Lipids Revenue (2020-2025) & (US$ Million)

Table 112. Avanti Polar Lipids Recent Development

Table 113. Genevant Sciences Company Details

Table 114. Genevant Sciences Business Overview

Table 115. Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Product

Table 116. Genevant Sciences Revenue (2020-2025) & (US$ Million)

Table 117. Genevant Sciences Recent Development

Table 118. Nippon Fine Chemical Company Details

Table 119. Nippon Fine Chemical Business Overview

Table 120. Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Product

Table 121. Nippon Fine Chemical Revenue (2020-2025) & (US$ Million)

Table 122. Nippon Fine Chemical Recent Development

Table 123. Lipoid Company Details

Table 124. Lipoid Business Overview

Table 125. Lipoid Lipid Nanoparticle (LNP) Formulation Service Product

Table 126. Lipoid Revenue (2020-2025) & (US$ Million)

Table 127. Lipoid Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Type: 2024 VS 2031

Figure 3. Solid Lipid Nanoparticles Features

Figure 4. Nanostructured Lipid Carriers Features

Figure 5. Cationic Lipid-Nucleic Acid Complexes Features

Figure 6. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Application: 2024 VS 2031

Figure 8. Gene Therapy Case Studies

Figure 9. Vaccine Development Case Studies

Figure 10. Cancer Treatment Case Studies

Figure 11. Lipid Nanoparticle (LNP) Formulation Service Report Years Considered

Figure 12. Global Lipid Nanoparticle (LNP) Formulation Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Lipid Nanoparticle (LNP) Formulation Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Region: 2024 VS 2031

Figure 15. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Players in 2024

Figure 16. Global Top Lipid Nanoparticle (LNP) Formulation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Nanoparticle (LNP) Formulation Service as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Lipid Nanoparticle (LNP) Formulation Service Revenue in 2024

Figure 18. North America Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)

Figure 20. North America Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)

Figure 21. North America Lipid Nanoparticle (LNP) Formulation Service Market Share by Country (2020-2031)

Figure 22. United States Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)

Figure 26. Europe Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)

Figure 27. Europe Lipid Nanoparticle (LNP) Formulation Service Market Share by Country (2020-2031)

Figure 28. Germany Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. China Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. China Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)

Figure 36. China Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)

Figure 37. Asia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)

Figure 39. Asia Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)

Figure 40. Asia Lipid Nanoparticle (LNP) Formulation Service Market Share by Region (2020-2031)

Figure 41. Japan Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. China Taiwan Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Share by Type (2020-2031)

Figure 49. Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Share by Application (2020-2031)

Figure 50. Middle East, Africa, and Latin America Lipid Nanoparticle (LNP) Formulation Service Market Share by Country (2020-2031)

Figure 51. Brazil Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Mexico Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Turkey Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Israel Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. GCC Countries Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. GenScript Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 58. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 59. Merck Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 60. Cytiva Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 61. WuXi STA Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 62. Carcell Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 63. Croda International Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 64. Detai Biotechnology Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 65. Waters Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 66. MicroNano Biologics Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 67. Precigenome Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 68. Evonik Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 69. Avanti Polar Lipids Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 70. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 71. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 72. Lipoid Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2020-2025)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed